On-Demand Webinars
-
HPAPI Drug Product Development And Manufacturing Using Micronization Technology
Learn how to classify HPAPIs in early development and recommendations for safe product handling, from clinical manufacturing to commercialization.
-
Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion
Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.
-
Navigating Primary Packaging Challenges, Solutions For Emerging Innovators
12/5/2024
If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.
-
Novel Applications In Pharmaceutical Spray Drying
3/10/2025
Whether working with small-scale formulations or preparing for commercial manufacturing, this session will provide actionable strategies to optimize development pipelines.
-
Dry Powder Inhalable Vaccines For Shelf Stability And Global Access
6/3/2024
What if a formulation that removed the need for cold chain distribution was possible? Explore the formulation of vaccines and manufacturing considerations for dry powder inhaled vaccines.
-
Nanoparticle Enabled Formulation And Drug Delivery Solutions
Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.
-
Selecting Containers For Sensitive And Costly Cell & Gene Therapies
Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.
-
OSD Manufacturing For Pediatrics And Other Special Patient Populations
8/29/2024
Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.
-
Regulatory, Cost Implications Of Switching Injectable Delivery Formats
Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit.
-
Identify And Mitigate Absorption Risks With PBPK Modeling
3/12/2024
See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.